Edeniq Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Edeniq General Information

Description

Developer of cellulosic and biorefining technologies designed to produce low-cost cellulosic sugars and cellulosic ethanol. The company's cellulosic ethanol products can be easily integrated into existing biorefineries that produce ethanol, other biofuels, biochemicals, and bio-based products, enabling biorefineries to produce valuable cellulosic ethanol while also increasing throughput, yields, and corn oil production.

Contact Information

Website
www.edeniq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1105 North Nevada Street
  • Visalia, CA 93291
  • United States
+1 (559)
Primary Industry
Commodity Chemicals
Other Industries
Biotechnology
Corporate Office
  • 1105 North Nevada Street
  • Visalia, CA 93291
  • United States
+1 (559)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edeniq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Later Stage VC 24-Mar-2026 Completed Generating Revenue
17. Later Stage VC (Series D) 18-Feb-2022 Completed Generating Revenue
16. Later Stage VC 16-Jan-2020 Completed Generating Revenue
15. Secondary Transaction - Private Completed Generating Revenue
14. Secondary Transaction - Private 01-Oct-2019 Completed Generating Revenue
13. Debt - General 28-Mar-2018 Completed Generating Revenue
12. Later Stage VC (Series C) 01-Aug-2017 Completed Generating Revenue
11. Later Stage VC (Series B) 23-Jun-2017 Completed Generating Revenue
10. Merger/Acquisition 19-Jan-2017 $25.6M Cancelled Generating Revenue
9. Later Stage VC 01-May-2015 $1.4M $102M Completed Generating Revenue
To view Edeniq’s complete valuation and funding history, request access »

Edeniq Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1 2,399,209 $0.001000 7% $0.43 $0.43 1x $0.43 4.21%
Series A 896,880 $0.001000 7% $0.43 $0.43 1x $0.43 1.57%
To view Edeniq’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Edeniq Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cellulosic and biorefining technologies designed to produce low-cost cellulosic sugars and cellulosic ethan
Commodity Chemicals
Visalia, CA
52 As of 2026

Emeryville, CA
 

Pearl River, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edeniq Competitors (4)

One of Edeniq’s 4 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Anellotech Venture Capital-Backed Pearl River, NY
Ecovia Bio Venture Capital-Backed Livonia, MI
GFBiochemicals Venture Capital-Backed Aix-En-Provence, France
To view Edeniq’s complete competitors history, request access »

Edeniq Patents

Edeniq Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11913060-B1 Methods for quantifying mixed-linkage beta glucan Active 21-Dec-2018
US-12571022-B2 Methods for quantifying mixed-linkage beta glucan Active 21-Dec-2018
US-20240158830-A1 Methods for quantifying mixed-linkage beta glucan Active 21-Dec-2018
US-10954547-B1 Methods for quantifying starch and cellulose in corn samples Active 21-Dec-2017
US-12571021-B2 Methods for quantifying starch and cellulose in corn samples Active 21-Dec-2017 C12Q1/34
To view Edeniq’s complete patent history, request access »

Edeniq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edeniq Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Trinity Capital Inc BDC Business Development Company Minority
Flint Hills Resources Corporation Minority
California Energy Commission Government
U.S. Department of Energy Government
Angeleno Group Growth/Expansion Minority
To view Edeniq’s complete investors history, request access »

Edeniq Acquisitions (1)

Edeniq’s most recent deal was a Merger/Acquisition with Primafuel. The deal was made on 08-Jun-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Primafuel 08-Jun-2010 Merger/Acquisition Other Energy Services
To view Edeniq’s complete acquisitions history, request access »

Edeniq FAQs

  • When was Edeniq founded?

    Edeniq was founded in 2008.

  • Where is Edeniq headquartered?

    Edeniq is headquartered in Visalia, CA.

  • What is the size of Edeniq?

    Edeniq has 52 total employees.

  • What industry is Edeniq in?

    Edeniq’s primary industry is Commodity Chemicals.

  • Is Edeniq a private or public company?

    Edeniq is a Private company.

  • What is Edeniq’s current revenue?

    The current revenue for Edeniq is .

  • How much funding has Edeniq raised over time?

    Edeniq has raised $124M.

  • Who are Edeniq’s investors?

    Trinity Capital Inc BDC, Flint Hills Resources, California Energy Commission, U.S. Department of Energy, and Angeleno Group have invested in Edeniq.

  • Who are Edeniq’s competitors?

    Amyris (Biotechnology), Anellotech, Ecovia Bio, and GFBiochemicals are competitors of Edeniq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process